Our Main Goal

We bridge engineering and biology to advance the development
of new biopharmaceuticals.

Bioengineering for Cell-based Therapies

Advanced Technologies for Gene Therapy Products

Advanced Cell Models for Drug Discovery and Translational Research

Translational Immunology

Protein Biophysics for Drug Discovery

Vaccines Bioprocess Engineering

Biopharma

Natural Bioactives & Nutraceuticals

Microbiology and Molecular Biology

Sustainability for Food & Health
For Partners

We create value by leveraging our scientific and technological knowledge in Biology and Engineering. We develop improved and innovative bioprocesses, products and analytical tools. We work to maximize knowledge transfer between academia and industry.

>150

R&D projects with industry partners

For Scientists

We employ, train, and develop interdisciplinary and creative scientists to work at the interface between technological development and tech transfer. We offer cutting-edge infrastructure for biotechnology research. We fund original ideas from early-career scientists through iBETXplore innovation program.

110

PhD holders and over 40 PhD students distinguish our highly qualified research community

Right now we are developing
a next-generation vaccine against malaria.

Our scientists are producing
heart cells to build an artificial ventricle.

We are culturing mini-brain tumours to help companies
test ground-breaking anti-cancer therapies.

  • news
  • publications
Awards News

iBET’s R&D within the BRAVƎ European Consortium Recognized as Key Innovation by the European Commission
March 11, 2026
Awards News

iBET’s Partnering Project ADDovenom Gains Recognition from the European Commission
September 4, 2025
iNOVA4Health Seminars

Advanced 3D Cell Models for Preclinical Research: iBET Welcomes Visit and Seminar by Dr. Eckhard von Keutz
March 4, 2026
Events & Meetings

Tiago Bandeiras Highlights iBET-Merck Scientific Collaboration at Merck Portugal Annual Kick-off Event
January 27, 2026
Conferences

Advancing Animal Cell Technology and Biopharma R&D in Japan: iBET at JAACT2025
January 27, 2026
On the Media

“Reshaping Preclinical Research Through 3D Cell Models” – Podcast Interview with Catarina Brito
January 23, 2026

An integrative structural biology approach reveals the dynamic organization of the R2SP quaternary chaperone complex
Nature Communications
Publication 2026

Scaling the manufacture of adipose tissue-derived mesenchymal stromal cells: integrated bioreactor workflows from inoculation to harvest without the need of seed train
BMC Biotechnology
Publication 2026

Development of a serum-free producer cell line generation process for scalable and efficient rAAV production for gene therapy applications
Journal of Biotechnology
Publication 2026

Billion‐Scale Expansion of Functional hiPSC‐Derived Cardiomyocytes in Bioreactors Through Oxygen Control and Continuous Wnt Activation
Advanced Science
Publication 2025

Continuous Production of Influenza VLPs Using IC‐BEVS and Multi‐Stage Bioreactors
Biotechnology and Bioengineering
Publication 2025

Addressing neuroinflammation in human induced pluripotent stem cell-derived central nervous system neurospheroids
iScience
Publication 2025

3D co-cultures of primary human hepatocytes and Kupffer-like cells to address innate immune responses to rAAV
Scientific Reports
Publication 2025

iBET in Numbers

270

iBET staff working on biotech solutions of tomorrow

60

State-of-the-art R&D labs equipped with the latest cell culture and bioanalytical equipment

90

Public and privately funded ongoing R&D projects

>400

Peer-reviewed publications in the last 5 years

3.5 M€

Invested in internal innovation through our iBETXplore Program
Interested in working together?

Contact us
Manuel Carrondo

    At iBET, we work at the forefront of ATMPs and vaccine technologies to deliver the best value to our partners.

    Paula Alves

    iBET CEO

    iBET, committed to excellence for Biopharmaceuticals research and development.

    Manuel Carrondo

    iBET Vice President

    Jobs and Training

    MSc and PhD Training

    At iBET you will find a truly interdisciplinary team (engineers, biologists, biochemists, data scientists) plus cutting-edge research facilities to pursue your academic research training in Biotechnology and Life Sciences. Our focus on applied research and knowledge transfer to industry offers you a unique setting to broaden your career perspectives in close contact to the job market.

    Learn more
    Job Offers
    Careers

    Join an interdisciplinary and agile team driven by ambition, commitment, and innovation. With a focus on technological progress, continuous improvement, and career development, we offer continuous growth opportunities. Come be part of our mission to provide biotech solutions to our industry partners.

    Learn more